Bokisch V A, Sobel A T
J Exp Med. 1974 Nov 1;140(5):1336-47. doi: 10.1084/jem.140.5.1336.
This report describes receptors for C4b on human peripheral B lymphocytes. The simultaneous presence of C3b and C4b receptors on the same lymphocytes was demonstrated by the formation of mixed rosettes consisting of the lymphocytes, EAC14 and EAC1423. Furthermore, reduction of the number of EAC1423 rosette-forming lymphocytes in a lymphocyte population by albumin gradient centrifugation concomitantly reduced EAC14 rosette-forming lymphocytes. Binding of EAC14 intermediates to receptors on human lymphocytes and erythrocytes could be inhibited by equal amounts of soluble C3b or C4b, suggesting the presence of a single receptor for both ligands on those cells. In contrast, the results of the rosette assay with Raji cells, cultured human lymphoblastoid cells, EAC14 and EAC1423 suggested that the receptors for C4b and C3b are distinct entities, since Raji cells formed rosettes with EAC1423, but not with EAC14. Moreover, this report demonstrates a cooperation of erythrocyte-bound C4b and C3b in the binding of EAC1423 to B lymphocytes. In contrast to KAF-treated C3b, KAF-treated C4b did not bind to B lymphocytes, indicating that these cells lack a receptor for C4d.
本报告描述了人外周血B淋巴细胞上C4b的受体。通过由淋巴细胞、EAC14和EAC1423组成的混合玫瑰花结的形成,证明了同一淋巴细胞上同时存在C3b和C4b受体。此外,通过白蛋白梯度离心减少淋巴细胞群体中形成EAC1423玫瑰花结的淋巴细胞数量,同时也减少了形成EAC14玫瑰花结的淋巴细胞数量。等量的可溶性C3b或C4b可抑制EAC14中间体与人淋巴细胞和红细胞上受体的结合,表明这些细胞上存在这两种配体的单一受体。相比之下,用Raji细胞(培养的人淋巴母细胞样细胞)、EAC14和EAC1423进行玫瑰花结试验的结果表明,C4b和C3b的受体是不同的实体,因为Raji细胞与EAC1423形成玫瑰花结,但不与EAC14形成玫瑰花结。此外,本报告证明了红细胞结合的C4b和C3b在EAC1423与B淋巴细胞结合中的协同作用。与KAF处理的C3b不同,KAF处理的C4b不与B淋巴细胞结合,表明这些细胞缺乏C4d受体。